Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Calabrese

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
JAMA|August 14, 1987
The treatment of vasculitis of the central nervous systemL H Calabrese, J A Mallek
Medicine|January 1, 1988
Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteriaL H Calabrese, J A Mallek
Clinics in Sports Medicine|November 1, 1983
Nutritional and medical considerations in dancersL H Calabrese, D T Kirkendall
Annals of the Rheumatic Diseases|October 14, 2004
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infectionL H Calabrese, N Zein, D Vassilopoulos
Pathogens & Immunity|May 10, 2021
The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?N Winchester, C Calabrese, L H Calabrese
Cleveland Clinic Journal of Medicine|March 1, 1990
Urticaria, nephritis, and pseudotumor cerebriJ Lieberman, G Gephardt, L H Calabrese
The Laryngoscope|July 17, 1998
Dysphagia in patients with inclusion body myositisS M Houser, L H Calabrese, M Strome
Rheumatic Diseases Clinics of North America|February 1, 1995
Therapy of resistant systemic necrotizing vasculitis. Polyarteritis, Churg-Strauss syndrome, Wegener's granulomatosis, and hypersensitivity vasculitis group disordersL H Calabrese, G S Hoffman, L Guillevin
Arthritis and Rheumatism|April 1, 1987
Inclusion body myositis presenting as treatment-resistant polymyositisL H Calabrese, H Mitsumoto, S M Chou
Annals of the Rheumatic Diseases|April 22, 2006
Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategiesL H Calabrese, N N Zein, D Vassilopoulos
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
JAMA|August 14, 1987
The treatment of vasculitis of the central nervous systemL H Calabrese, J A Mallek
Medicine|January 1, 1988
Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteriaL H Calabrese, J A Mallek
Clinics in Sports Medicine|November 1, 1983
Nutritional and medical considerations in dancersL H Calabrese, D T Kirkendall
Annals of the Rheumatic Diseases|October 14, 2004
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infectionL H Calabrese, N Zein, D Vassilopoulos
Pathogens & Immunity|May 10, 2021
The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?N Winchester, C Calabrese, L H Calabrese
Cleveland Clinic Journal of Medicine|March 1, 1990
Urticaria, nephritis, and pseudotumor cerebriJ Lieberman, G Gephardt, L H Calabrese
The Laryngoscope|July 17, 1998
Dysphagia in patients with inclusion body myositisS M Houser, L H Calabrese, M Strome
Rheumatic Diseases Clinics of North America|February 1, 1995
Therapy of resistant systemic necrotizing vasculitis. Polyarteritis, Churg-Strauss syndrome, Wegener's granulomatosis, and hypersensitivity vasculitis group disordersL H Calabrese, G S Hoffman, L Guillevin
Arthritis and Rheumatism|April 1, 1987
Inclusion body myositis presenting as treatment-resistant polymyositisL H Calabrese, H Mitsumoto, S M Chou
Annals of the Rheumatic Diseases|April 22, 2006
Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategiesL H Calabrese, N N Zein, D Vassilopoulos
Pageof 17